title: Implementation of TPMT testing.
abstract: The activity of the enzyme thiopurine methyltransferase (TPMT) is regulated by a common genetic polymorphism. One in 300 individuals lack enzyme activity and 11% are heterozygous for a variant low activity allele and have an intermediate activity. The thiopurine drugs azathioprine, mercaptopurine and thioguanine are substrates for TPMT; these drugs exhibit well documented myelosuppressive effects on haematopoietic cells and have a track record of idiosyncratic drug reactions. The development of severe bone marrow toxicity, in patients taking standard doses of thiopurine drugs, is associated with TPMT deficiency whilst the TPMT heterozygote is at an increased risk of developing myelosuppression. Factors influencing TPMT enzyme activity, as measured in the surrogate red blood cell, are discussed in this review to enable an appreciation of why concordance between TPMT genotype and phenotype is not 100%. This is particularly important for lower/intermediate TPMT activities to avoid misclassification of TPMT status. TPMT testing is now widely available in routine service laboratories. The British National Formulary suggests TPMT testing before starting thiopurine drugs. Dermatologists were quick to adopt routine TPMT testing whilst gastroenterologists do not specifically recommend TPMT screening. TPMT testing is mandatory prior to the use of mercaptopurine in childhood leukaemia. Thiopurine drug dose and other treatment related influences on cell counts explain some of the differing recommendations between clinical specialities. TPMT testing is cost-effective and the major role is in the identification of the TPMT deficient individual prior to the start of thiopurine drugs.
authors: Clinical Pharmacology Unit, Department of Human Metabolism, University of Sheffield, Sheffield, UK.
authors: Lynne
authors: L
authors: Lennard
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000493:pharmacokinetics; D001379:Azathioprine / Q000009:adverse effects / Q000493:pharmacokinetics; D003362:Cost-Benefit Analysis / Q000191:economics; D004342:Drug Hypersensitivity / Q000175:diagnosis*; D004348:Drug Labeling / Q000592:standards; D005820:Genetic Testing / Q000191:economics*; D005838:Genotype; D006801:Humans; D015122:Mercaptopurine / Q000009:adverse effects / Q000493:pharmacokinetics; D008780:Methyltransferases / Q000235:genetics* / Q000378:metabolism; D010641:Phenotype; D011686:Purine-Pyrimidine Metabolism, Inborn Errors / Q000175:diagnosis*; D013866:Thioguanine / Q000009:adverse effects* / Q000493:pharmacokinetics
chemical_list: D000964:Antimetabolites, Antineoplastic; D015122:Mercaptopurine; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D013866:Thioguanine; D001379:Azathioprine
keywords: TPMT; azathioprine; childhood leukaemia; mercaptopurine; thioguanine nucleotides; thiopurine methyltransferase
references: Am J Gastroenterol. 2006 Dec;101(12):2769-76
references: 17026564
references: Blood. 2002 Aug 15;100(4):1240-7
references: 12149204
references: J Pediatr Hematol Oncol. 2000 Sep-Oct;22(5):441-5
references: 11037857
references: Lancet. 1986 Jan 18;1(8473):156
references: 2867372
references: Clin Pharmacol Ther. 1992 Jan;51(1):24-31
references: 1732075
references: J Pediatr. 1991 Dec;119(6):985-9
references: 1960624
references: Br J Clin Pharmacol. 1995 Apr;39(4):456-9
references: 7640156
references: J Pediatr Hematol Oncol. 2002 Jun-Jul;24(5):353-9
references: 12142782
references: Gut. 2011 Dec;60(12):1611-29
references: 21757447
references: Eur J Clin Pharmacol. 1993;44(2):147-52
references: 8453958
references: Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):949-53
references: 7862671
references: Clin Pharmacol Ther. 2009 Jul;86(1):109-13
references: 19369936
references: Clin Pharmacol Ther. 1994 Jan;55(1):15-20
references: 8299312
references: Am J Hum Genet. 1980 Sep;32(5):651-62
references: 7191632
references: J Pharmacol Exp Ther. 1982 Jul;222(1):174-81
references: 7086699
references: Aliment Pharmacol Ther. 2002 Mar;16(3):389-98
references: 11876691
references: Inflamm Bowel Dis. 2006 Apr;12(4):251-7
references: 16633046
references: Pharmacogenetics. 1999 Feb;9(1):37-42
references: 10208641
references: Gut. 2001 Nov;49(5):665-70
references: 11600469
references: Hum Mol Genet. 1999 Feb;8(2):371-6
references: 9931346
references: Ther Drug Monit. 2008 Jun;30(3):390-3
references: 18520612
references: Clin Pharmacol Ther. 1997 Jul;62(1):60-73
references: 9246020
references: Drug Ther Bull. 2009 Jan;47(1):9-12
references: 19129430
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Apr 13;834(1-2):77-83
references: 16517227
references: J Crohns Colitis. 2012 Jul;6(6):655-9
references: 22398041
references: Aliment Pharmacol Ther. 2012 May;35(10):1181-9
references: 22486532
references: Br J Dermatol. 2011 Oct;165(4):711-34
references: 21950502
references: Clin Biochem. 2010 Jan;43(1-2):37-42
references: 19748501
references: Pharmacogenomics. 2009 Nov;10(11):1753-65
references: 19891552
references: J Clin Pathol. 2010 Apr;63(4):288-95
references: 20354201
references: J Natl Cancer Inst. 1999 Dec 1;91(23):2001-8
references: 10580024
references: BMJ. 2005 Feb 12;330(7487):350-1
references: 15705694
references: Ann Intern Med. 2011 Jun 21;154(12):814-23, W-295-8
references: 21690596
references: Biochem Genet. 1982 Aug;20(7-8):637-58
references: 7138494
references: Clin Pharmacol Ther. 1989 Aug;46(2):149-54
references: 2758725
references: Rheumatology (Oxford). 2007 May;46(5):727-9
references: 17255139
references: Pharmacogenomics. 2011 Jun;12(6):815-26
references: 21692613
references: Clin Chem. 2004 Feb;50(2):438-41
references: 14752016
references: Gut. 2004 Aug;53(8):1123-8
references: 15247179
references: Pharmacogenetics. 1995 Oct;5(5):281-6
references: 8563768
references: Biochem Pharmacol. 1994 Nov 29;48(11):2135-8
references: 7802704
references: Pharmacogenet Genomics. 2011 Jun;21(6):313-24
references: 21372752
references: Pharmacogenet Genomics. 2013 Apr;23(4):242-8
references: 23407052
references: Pharmacogenetics. 1992 Aug;2(4):148-59
references: 1306116
references: Pharmacogenetics. 1999 Apr;9(2):189-98
references: 10376766
references: Pharmacogenomics. 2010 Feb;11(2):177-88
references: 20136357
references: Eur J Clin Pharmacol. 2008 Apr;64(4):373-9
references: 18193212
references: J Rheumatol. 2002 Dec;29(12):2507-12
references: 12465143
references: Hepatology. 2010 Jun;51(6):2193-213
references: 20513004
references: Br J Dermatol. 2004 Dec;151(6):1123-32
references: 15606506
references: Am J Gastroenterol. 2005 Oct;100(10):2239-47
references: 16181376
references: Clin Pharmacol Ther. 2011 Mar;89(3):387-91
references: 21270794
references: J Chromatogr B Biomed Appl. 1994 Nov 4;661(1):25-33
references: 7866549
references: Lancet. 1990 Jul 28;336(8709):225-9
references: 1973780
references: Eur J Cancer. 2005 Mar;41(4):613-23
references: 15737567
references: Br J Ophthalmol. 2006 Jul;90(7):923-4
references: 16782959
references: J Clin Oncol. 1995 Feb;13(2):345-51
references: 7531219
references: Clin Pharmacol Ther. 2006 Oct;80(4):375-83
references: 17015055
references: Cancer Res. 1974 Apr;34(4):738-46
references: 4856046
references: Clin Pharmacol Ther. 1997 Oct;62(4):464-75
references: 9357398
references: J Clin Invest. 2003 Apr;111(8):1133-45
references: 12697733
references: Pharmacogenetics. 2004 Jul;14(7):407-17
references: 15226673
references: Clin Chim Acta. 1978 May 2;85(3):323-33
references: 657528
references: J Clin Pharm Ther. 2007 Apr;32(2):187-95
references: 17381669
references: Br J Clin Pharmacol. 1984 Feb;17(2):171-2
references: 6704287
references: Pharmacogenomics. 2002 Jan;3(1):89-98
references: 11966406
references: Clin Pharmacol Ther. 1996 Jul;60(1):68-74
references: 8689814
references: Gastroenterology. 2002 Apr;122(4):904-15
references: 11910342
references: Br J Clin Pharmacol. 2006 Oct;62(4):473-6
references: 16995868
references: Oncogene. 2006 Mar 13;25(11):1629-38
references: 16550163
references: Br Med Bull. 2006;79-80:153-70
references: 17277075
references: J Pharmacol Exp Ther. 1993 Jul;266(1):23-32
references: 8392551
references: Gut. 2004 Sep;53 Suppl 5:V1-16
references: 15306569
references: Br J Clin Pharmacol. 2001 Nov;52(5):539-46
references: 11736862
references: Gastroenterology. 2000 Apr;118(4):705-13
references: 10734022
references: Dig Dis Sci. 2007 May;52(5):1262-9
references: 17334911
references: DNA Cell Biol. 1996 Jan;15(1):17-30
references: 8561894
references: Blood. 2006 Jan 15;107(2):843-4
references: 16401827
references: J Clin Oncol. 2003 Apr 1;21(7):1332-9
references: 12663723
references: Inflamm Bowel Dis. 2011 Dec;17(12):2480-7
references: 21351210
references: Blood. 1998 Nov 15;92(10):3569-77
references: 9808549
references: Gut. 1996 Sep;39(3):401-6
references: 8949645
references: Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1033-7
references: 17065060
references: Lancet. 1993 Feb 13;341(8842):436
references: 8094196
references: Scand J Clin Lab Invest. 1993 Nov;53(7):747-9
references: 8272762
references: Rheumatology (Oxford). 2008 Jun;47(6):924-5
references: 16940305
references: QJM. 2002 Jul;95(7):439-44
references: 12096148
references: Clin Pharmacol Ther. 2000 Aug;68(2):210-9
references: 10976552
references: Clin Chem. 2005 Nov;51(11):2074-84
references: 16166171
references: J Immunol. 2006 Jan 1;176(1):640-51
references: 16365460
references: Aliment Pharmacol Ther. 2006 Jul 15;24(2):331-42
references: 16842460
references: J Chromatogr B Biomed Sci Appl. 1998 Jan 23;705(1):29-37
references: 9498667
references: Lancet. 2006 Mar 11;367(9513):839-46
references: 16530578
references: J Clin Pharm Ther. 2007 Dec;32(6):633-9
references: 18021342
references: Blood. 1995 Apr 1;85(7):1897-902
references: 7703493
references: Gut. 2011 May;60(5):571-607
references: 21464096
references: Mol Pharmacol. 1983 Nov;24(3):471-8
references: 6633508
references: Am J Gastroenterol. 2007 Dec;102(12):2747-53
references: 17764493
references: Eur J Clin Pharmacol. 1999 Jun;55(4):285-91
references: 10424321
references: Clin Pharmacol Ther. 2013 Apr;93(4):324-5
references: 23422873
references: Br J Clin Pharmacol. 2013 Jul;76(1):125-36
references: 23252716
references: Ann Clin Biochem. 2009 Mar;46(Pt 2):152-4
references: 19164342
references: Ther Drug Monit. 2007 Feb;29(1):1-5
references: 17304143
references: Pharmacogenetics. 1999 Dec;9(6):773-6
references: 10634140
references: J Clin Oncol. 1989 Dec;7(12):1816-23
references: 2585022